Now accepting new patients in River Oaks, Houston. Request your assessment →
It just needs the right conditions.
The man who has always operated at a high level notices when his output doesn't match his input. The program starts with a comprehensive panel, names what has changed, and builds a physician-guided protocol around restoring it.
Most men who come to this program are not looking for a hormone clinic. They are looking for an explanation — one grounded in their actual numbers, not in what is most common for a man their age.
They know enough to know that "normal range" is a population average, not an individual target. What they haven't had is a physician who looked at the complete picture and told them the truth about what it shows. The evidence on testosterone and male health outcomes is reviewed at PubMed (PMID 31384712).
This program begins with a comprehensive panel — testosterone (total and free), estradiol, SHBG, LH, FSH, thyroid, cortisol, DHEA-S, and metabolic markers. Your physician reviews every number with you. The protocol — TRT, peptide support, or a combination — is determined by what the data specifically indicates. To understand how the program structure and follow-up work, see How It Works.
Peptide therapy — growth hormone secretagogues and other clinically appropriate peptides — is integrated where the panel supports it and the clinical picture warrants it, sourced compliantly. The goal is not the highest possible numbers. It is the level at which you function best — and maintaining it over time.
Comprehensive Hormonal Panel
Total and free testosterone, estradiol, SHBG, LH, FSH, DHEA-S, thyroid (TSH, T3, T4), cortisol, IGF-1, CBC, and metabolic markers. Every number reviewed with your physician — not summarized, not filtered.
Testosterone Replacement Therapy
Physician-monitored TRT at the dose and delivery method your specific panel warrants — not a standard starting protocol. Estradiol conversion, hematocrit, and PSA are tracked at follow-up panels.
Peptide Therapy
Where clinically indicated and sourced compliantly — growth hormone secretagogues and targeted peptides that support the recovery, sleep architecture, and performance outcomes that hormonal correction creates the biological conditions for.
Follow-Up & Refinement
Panels at 6–8 weeks. Protocol adjusted to where your biology responds best — not where the population average falls. The first panel is the starting point. Every one after is the refinement.
Comprehensive bloodwork covering the full hormonal picture. Your physician reviews every marker with you — what it means, where you fall, and what the data suggests about where you should be. This is the conversation most men have never had.
TRT initiated at the dose and modality your panel specifically warrants. Peptide support and ancillary corrections added where indicated. The protocol is yours — built from your data, not a standard starting point applied to every new patient.
Panel at 6–8 weeks. Estradiol conversion, hematocrit, PSA, and hormone levels reviewed. Protocol refined. Most men require adjustment in the first cycle — that is not a failure of the protocol, it is the protocol working as designed.
Energy and mood typically shift within 3–6 weeks. Cognitive clarity, recovery, and physical performance follow at 2–3 months as levels stabilize. The compounding effect — what most Valerians describe as feeling like themselves again — deepens the longer the program is maintained at the right levels.
This one starts with your numbers. The protocol follows from what the data specifically shows — not from what is most commonly prescribed for a man your age. That distinction is what separates a physician-guided program from a hormone clinic. Where metabolic function is also a factor, see Men's Metabolic Health — the two programs often run together.
TRT at Valere is not a subscription service. It is a physician-guided protocol initiated after a comprehensive panel, monitored with follow-up bloodwork, and refined based on how your biology responds. The physician is the constant — not the algorithm.
Reference ranges are built on averages. The goal of this program is to find where you function best — cognitively, physically, and hormonally — and build a protocol around maintaining it. That target is individual. It requires a physician who understands that.
Long-term considerations, fertility implications, monitoring requirements — your physician reviews all of it at assessment. No sales framing. No overstated outcomes. The information you need to make an informed decision about your own biology.
Where hormonal health intersects with metabolic function, body composition, or sexual wellness — those variables are addressed within the same program. Not referred out. The Valerian is the whole picture. The plan reflects that.
Normal range is built on population averages — it tells you where most men fall, not where you function best. A man at the bottom of normal range may have significantly different energy, clarity, and recovery than the same man at the upper third of that range. The question this program asks is not whether you are in range — it is where in range you actually feel like yourself. The relationship between testosterone levels and cognitive and physical performance is reviewed at PubMed (PMID 31384712). If metabolic variables are also a factor, see Men's Metabolic Health — the two programs often run together.
Yes — this is one of the most important questions to ask before starting, and your physician will address it directly at assessment. Exogenous testosterone suppresses the body's natural production of LH and FSH, which are required for sperm production. For men who have not yet completed their family, this is a significant consideration. Fertility-preserving alternatives — such as HCG or clomiphene — are options your physician will discuss based on your specific situation. This conversation happens before any protocol is initiated, not after.
TRT requires ongoing management — it is not a prescription you take without monitoring. Hematocrit, estradiol, PSA, and lipid panels are tracked at regular intervals. Fertility implications are relevant for men who have not yet completed their family. The long-term cardiovascular data on well-managed TRT has improved significantly — the 2023 TRAVERSE trial and subsequent FDA label changes in 2025 removed the prior cardiovascular black-box warning for testosterone products. Your physician will review the complete clinical picture at your assessment.
This question has been significantly clarified by recent evidence. The 2023 TRAVERSE trial — the largest cardiovascular outcomes study on testosterone replacement — demonstrated that TRT did not increase the risk of major adverse cardiovascular events in men with hypogonadism and existing cardiovascular risk. Based on this data, the FDA removed the broad cardiovascular black-box warning from testosterone products in 2025. Well-managed TRT in appropriate candidates, with monitoring of hematocrit and blood pressure, has a favorable safety profile. Your physician reviews your complete cardiovascular history before any protocol is recommended. See our physician's clinical approach for how this is evaluated.
Your assessment begins with a comprehensive panel. Your physician reviews every marker with you. The plan follows from what the data shows — not from what is most commonly prescribed.
Reserve Your AssessmentPrivate · By appointment only · River Oaks, Houston